CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
about
Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundanceCD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myelomaCD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline MotifTreatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.CD28-B7 interaction modulates short- and long-lived plasma cell function.Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma.Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapyNovel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.EPHA3 as a novel therapeutic target in the hematological malignancies.Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies.Characterization of a new human plasma cell leukemia cell line UHKT-944.The multi-faceted potential of CD38 antibody targeting in multiple myeloma.Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells.Pre-existing malignancy results in increased prevalence of distinct populations of CD4+ T cells during sepsis.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
P2860
Q33662759-251B4CF9-1918-4FAD-899C-D95D8F464234Q33749646-60C254A6-74B6-4BE1-A06C-34905798F3A1Q35560706-B998E218-D895-4D13-A32B-6E14FFB32CA5Q35927877-6E957AD0-C96D-40A6-AC34-FFF7CBF5828DQ36117230-6E0121AD-BDD0-4271-9CDE-53E346A5D61EQ36821053-5CFC8978-2DAF-4891-8796-FF9CE685E40FQ36849492-9484C939-EC27-4A2C-85A6-4A0BD7E0DE0FQ37022378-0DAC4C0B-C853-402B-B2F7-54BB7505DF73Q37035522-39A92CAA-3854-4D41-B161-06D952D56BB6Q37635827-6BDD5DFA-722B-4A71-92DC-3450DF7E0D7AQ37722551-AB019A4C-200A-4686-82E6-5E4FB540F59CQ38008379-5459C39B-ECE1-4D5B-BE0E-A0E563C59D7AQ38025161-6F0A28FA-A20A-4C8F-9839-38098908AC62Q38357132-0AF01827-A08F-4CF6-9734-C15472F0F85EQ38918719-0490FC03-A70C-498D-9533-F3B4CFABB2E1Q39200031-633CF443-30DE-4157-AF7E-8FA24D7A5D4FQ39901834-A6566281-B27F-4CC4-860F-0E054A59F31FQ41190391-F87B4730-5F8F-472B-A320-999B1A4B703DQ41855192-6F10A022-1875-4E26-95D8-3C2470548253Q48235160-9E5D8C67-2FE5-4D5D-B28D-A7C3708DB1CFQ49641900-5EC4B2C4-027C-47FB-9D2E-12AB716DE9AFQ49830211-7A4FB2C7-A157-4968-B99A-F5C3D9B11AEB
P2860
CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@en
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@nl
type
label
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@en
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@nl
prefLabel
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@en
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@nl
P2093
P2860
P356
P1476
CD28 expressed on malignant pl ...... osuppressive microenvironment.
@en
P2093
Asher Chanan-Khan
Chandana Koorella
Cheryl H Rozanski
Gerald E Byrne
Jayakumar R Nair
John P Shaughnessy
Kelvin P Lee
Lawrence H Boise
Louise M Carlson
P Leif Bergsagel
P2860
P304
P356
10.4049/JIMMUNOL.1100016
P407
P577
2011-06-29T00:00:00Z